Page 55 - MemoriaEHD-Eng

www.ciberehd.org

• B M, r B, a v, D-v JC, N L, r a, p Ja,
ereNgueroCheguiLerauCLosaLLéeavarrouBíNoNsDe La Most relevant
Mata M, prieto M, saMueL D. Efficacy of the retreatment of hepatitis C virus infec-
scientific tions after liver transplantation: role of an aggressive approach.LIVER TRANSPLANT.

articles
2013;19(1):69-77.

• BereNguer M, sChuppaN D. Progression of liver fibrosis in post-transplant hepatitis C:

mechanisms, assessment and treatment.J Hepatol. 2013 May;58(5):1028-41.

• giusto M, BereNguer M, MerKeL C, aguiLera v, ruBiN a, giNaNNi CorraDiNi s et aL.. Chronic
kidney disease after liver transplantation: pretransplantation risk factors and predic-

tors during follow-up.Transplantation. 2013 May 15;95(9):1148-53.

• ruBíN a, sáNChez-MoNtes C, aguiLera v, JuaN Fs, Ferrer i, Moya a et aL.. Long-term outco-
me of ‘long-term liver transplant survivors’.Transpl Int. 2013 Jul;26(7):740-50.

• r-g M, B M, M e, C JL.. Management of anemia induced
oMeroóMezereNgueroLiNaaLLeJa
by triple therapy in patients with chronic hepatitis C: challenges, opportunities and
recommendations.J Hepatol. 2013;.

PROJECTS: One project from the Health Spanish Society (FIS) in line with the
Highlights
group research (PI: Dr Victoria Aguilera, Title: Specific cellular immune response
against cytomegalovirus following liver transplantation in patients with recurrent

hepatitis C”).

COLLABORATION WITH OTHER CIBEREHD GROUPS RELATED WITH THE PRO-
íñ
JECTS: (1) Immunologic tolerance (PI A. Sánchez Fueyos), (2) non-cirrhotic portal
hypertension (PI: JC García-Pagán); (3) Hepatotoxicity (PI: R. Andrade); (4) He-

patitis C in liver transplantation (PI: M Berenguer); (5) Post-liver transplantation
metabolic complications (diabetes mellitus) (PI: M Berenguer)

PUBLICATIONS: 10 (5 original articles, 4 reviews, 1 editorial). The 5 original

papers all in first quartile journals, in line with the group research main lines

(long-term complications in liver transplantation, hepatitis C). International co-
llaboration in 1 review, 1 editorial and 2 original articles. Collaboration with other

Ciberehd groups: 2 publications (1 review, 1 original article)

INVITED SPEAKER: (1) M.Berenguer: in 14 Conferences/Congresses (10 inter-
national). Including 2 participations in the American Association for the Study of

Liver Diseases Hepatitis Single Topic Conference: Hepatitis C treatment in special

populations. Atlanta, USA. 15-16 Feb 2013): Treatment of hepatitis C in the liver
transplant population, treatment of HCV-cryoglobulinemia; M. Prieto: in 2; V.

Aguilera: in 2 national meetings.

OTHER ACTIVITIES (1) M. Berenguer: Associate editor in Liver Transplantation (IF:

3,944) and Journal Hepatology (IF: 9,858). Councillor of the “Asociación Española
para el estudio del Hgado (AEEH)”, European Society of organ transplantation
13
(ESOT), and International Liver Transplantation Society; (2) M. Prieto: Councillor 20
of the “Sociedad Espaola de Trasplante Hep??tico (SETH)”
T
OR
P
RE
L
A
NU
N
A
D /
H
E
ER
IB
C

55